Literature DB >> 11264030

Current understanding and management of chronic hepatosplenic suppurative brucellosis.

J Ariza1, C Pigrau, C Cañas, A Marrón, F Martínez, B Almirante, J M Corredoira, A Casanova, J Fabregat, A Pahissa.   

Abstract

To outline the characteristics and define appropriate management of chronic hepatosplenic suppurative brucellosis (CHSB), 905 patients with brucellosis were analyzed. Sixteen episodes of CHSB (14 in the liver and 2 in the spleen) were found in 15 patients. Six patients had had previous remote brucellosis. Twelve patients presented with systemic symptoms, and 12 with local symptoms. Cultures of blood samples yielded negative results in all cases except 1, and the results of cultures of pus specimens were positive for Brucella melitensis in only 2 cases. All patients showed calcium deposits surrounded by a hypodense area on computed tomography. Patients often had low titers of agglutinating antibody. In patients who were receiving conservative management, early response was successful in 50% and late response was successful in 33.3%. In the patients who underwent surgery and concomitant antibiotic therapy, early and late response was successful in 100%. Thus, CHSB mainly represents a local reactivation of previous brucellosis. Its diagnosis may be difficult to establish and surgery may be required to cure many patients.

Entities:  

Mesh:

Year:  2001        PMID: 11264030     DOI: 10.1086/319608

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Late reactivation of calcified granuloma in a patient with chronic suppurative brucellosis.

Authors:  J D Colmenero; M A Suarez-Muñoz; M I Queipo-Ortuño; J M Reguera; P Morata
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-11       Impact factor: 3.267

2.  Secondary serological response of patients with chronic hepatosplenic suppurative brucellosis.

Authors:  R Díaz; J Ariza; I Alberola; A Casanova; M F Rubio
Journal:  Clin Vaccine Immunol       Date:  2006-08-30

3.  Different roles of the two high-oxygen-affinity terminal oxidases of Brucella suis: Cytochrome c oxidase, but not ubiquinol oxidase, is required for persistence in mice.

Authors:  Maria Pilar Jiménez de Bagüés; Séverine Loisel-Meyer; Jean-Pierre Liautard; Véronique Jubier-Maurin
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

4.  Multiple abscesses in brucellosis with Wright's test negativity.

Authors:  Luca Dutto; Fulvio Pomero; Attilio Allione
Journal:  BMJ Case Rep       Date:  2009-02-27

Review 5.  The current therapeutical strategies in human brucellosis.

Authors:  Mile Bosilkovski; Fariba Keramat; Jurica Arapović
Journal:  Infection       Date:  2021-03-01       Impact factor: 3.553

6.  Brucellosis among hospitalized febrile patients in northern Tanzania.

Authors:  Andrew J Bouley; Holly M Biggs; Robyn A Stoddard; Anne B Morrissey; John A Bartlett; Isaac A Afwamba; Venance P Maro; Grace D Kinabo; Wilbrod Saganda; Sarah Cleaveland; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

7.  Splenic abscess due to acute brucellosis.

Authors:  Mehmet Deveer; Hamdi Sozen; Nesat Çullu; Ali Kemal Sivrioglu
Journal:  BMJ Case Rep       Date:  2013-04-10

Review 8.  Patterns of Hepatosplenic Brucella Abscesses on Cross-Sectional Imaging: A Review of Clinical and Imaging Features.

Authors:  Tom Heller; Sabine Bélard; Claudia Wallrauch; Edoardo Carretto; Raffaella Lissandrin; Carlo Filice; Enrico Brunetti
Journal:  Am J Trop Med Hyg       Date:  2015-08-17       Impact factor: 2.345

9.  RegA, the regulator of the two-component system RegB/RegA of Brucella suis, is a controller of both oxidative respiration and denitrification required for chronic infection in mice.

Authors:  Elias Abdou; Amélie Deredjian; María Pilar Jiménez de Bagüés; Stephan Köhler; Véronique Jubier-Maurin
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

10.  Brucella liver abscess; imaging approach, differential diagnosis, and therapeutic management: a case report.

Authors:  Danai Chourmouzi; Glykeria Boulogianni; Maria Kalomenopoulou; Ioannis Kanellos; Antonios Drevelegas
Journal:  Cases J       Date:  2009-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.